Insights

Strategic Industry Collaborations Abolis Biotechnologies has established high-profile partnerships with major industry players like L’Oréal, Evonik, and EuroAPI, indicating strong interest from companies seeking sustainable and innovative biotech ingredients. This opens opportunities to offer complementary solutions such as novel micro-organism applications or advanced bioprocessing services tailored for large-scale manufacturing.

Funding and Investment Momentum Recent investments from Icos Capital and a €140 million alliance with EuroAPI highlight the company’s rapid growth and potential for expansion. Engaging with Abolis at this stage can provide opportunities to co-develop new products, enhance manufacturing capabilities, or supply specialized biotechnological inputs needed for scaled production.

Focus on Sustainability Abolis is committed to reducing greenhouse gases, using renewable raw materials, and securing supply chains, aligning with companies looking to enhance their sustainability profiles. Offering eco-friendly biotechnologies, green raw material sourcing, or sustainability consulting could be valuable sales areas.

Innovation in Biotech Solutions As a company that prioritizes research and development in micro-organism-based solutions, Abolis presents opportunities for sales teams to pitch cutting-edge biotech innovations that help clients develop sustainable ingredients, pharmaceuticals, or cosmetics, especially those interested in synthetic biology and bio-based materials.

Market Expansion Potential With a multidisciplinary approach targeting diverse sectors from healthcare to chemicals, Abolis is positioned for growth across multiple industries. Business development efforts could focus on creating customized biotechnological solutions for new verticals, expanding their reach into sectors such as food, beauty, and industrial manufacturing.

Abolis Biotechnologies Tech Stack

Abolis Biotechnologies uses 8 technology products and services including jsDelivr, cdnjs, Swiper, and more. Explore Abolis Biotechnologies's tech stack below.

  • jsDelivr
    Content Delivery Network
  • cdnjs
    Content Delivery Network
  • Swiper
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • PHP
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • Google Analytics
    Web Analytics
  • Apache HTTP Server
    Web Servers

Abolis Biotechnologies's Email Address Formats

Abolis Biotechnologies uses at least 1 format(s):
Abolis Biotechnologies Email FormatsExamplePercentage
First.Last@abolis.frJohn.Doe@abolis.fr
50%
First.Last@abolis.frJohn.Doe@abolis.fr
50%

Frequently Asked Questions

Where is Abolis Biotechnologies's headquarters located?

Minus sign iconPlus sign icon
Abolis Biotechnologies's main headquarters is located at 5 Rue Henri Desbruères Évry, Île-de-france 91030 France. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Abolis Biotechnologies's official website and social media links?

Minus sign iconPlus sign icon
Abolis Biotechnologies's official website is abolis.fr and has social profiles on LinkedInCrunchbase.

What is Abolis Biotechnologies's SIC code NAICS code?

Minus sign iconPlus sign icon
Abolis Biotechnologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abolis Biotechnologies have currently?

Minus sign iconPlus sign icon
As of February 2026, Abolis Biotechnologies has approximately 64 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Vp Operations | Head Of Operations, Transformation & Change Management: F. A.Head Of Business Development, North America: F. S.Head Of Scientific Business Development: T. C.. Explore Abolis Biotechnologies's employee directory with LeadIQ.

What industry does Abolis Biotechnologies belong to?

Minus sign iconPlus sign icon
Abolis Biotechnologies operates in the Biotechnology Research industry.

What technology does Abolis Biotechnologies use?

Minus sign iconPlus sign icon
Abolis Biotechnologies's tech stack includes jsDelivrcdnjsSwiperLodashPHPX-Content-Type-OptionsGoogle AnalyticsApache HTTP Server.

What is Abolis Biotechnologies's email format?

Minus sign iconPlus sign icon
Abolis Biotechnologies's email format typically follows the pattern of First.Last@abolis.fr. Find more Abolis Biotechnologies email formats with LeadIQ.

When was Abolis Biotechnologies founded?

Minus sign iconPlus sign icon
Abolis Biotechnologies was founded in 2014.

Abolis Biotechnologies

Biotechnology ResearchÎle-de-france, France51-200 Employees

Abolis is a French company delivering high-impact innovations in biotechnologies. We provide tailor-made industrial solutions based on micro-organisms.
Founded in 2014, Abolis is made up of a team of 66+ people. Determined to become a key player in the transformation of manufacturing, we reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals.
We rely on biotechnologies and the untapped potential of micro-organisms to develop new solutions economically viable.  
We take up the industry's current challenges by: 
·      Using renewable raw materials 
·      Relocate essential production and secure supply chains
·      Reducing greenhouse gas emissions 

Because each customer has its own unique story and challenges, we cultivate a multidisciplinary, tailor-made approach. Science, economics, intellectual property, industrial realities: each of our answers is based on the best possible practices. 
We are…
independent in thought and action
rigorous in our approach and the way we work
creative because we never stop innovating, while remaining pragmatic
ambitious because we are passionate and determined to make a difference

Section iconCompany Overview

Headquarters
5 Rue Henri Desbruères Évry, Île-de-france 91030 France
Website
abolis.fr
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $1M

    Abolis Biotechnologies's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Abolis Biotechnologies's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.